Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Classical hematology 1

Conditions

Multiple Myeloma 3Immunologic Deficiency Syndromes 2Thalassemia 1Neoplasms 1Myelodysplastic Syndromes 1Muscle Neoplasms 1Metabolic Diseases 1Melanoma 1Lymphoma 1Hemoglobinopathies 1Hematologic Neoplasms 1Fanconi Anemia 1Chronic Pain 1Breast Neoplasms 1Anemia, Sickle Cell 1Anemia, Aplastic 1

Interventions

fludarabine 2fludarabine phosphate 1Thiotepa 1Reverse Transcriptase Polymerase Chain Reaction 1Polymerase Chain Reaction 1Microarray Analysis 1Melphalan 1Immunoenzyme Techniques 1Electrophoresis, Polyacrylamide Gel 1Clofarabine 1Chromatography, High Pressure Liquid 1Chromatography 1Blotting, Western 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Fanconi Anemia × Melphalan × Clear all
NCT03609827 2021-10-04

Study of Melphalan Drug Exposure in Pediatric Hematopoietic Stem Cell Transplant Patients

University of California, San Francisco

Completed
25 enrolled
Classical hematologyOther hematologic neoplasm

Anemia, Sickle Cell, Fanconi Anemia, Hemoglobinopathies, Immunologic Deficiency Syndromes, Thalassemia, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡